Combination of atipamezole and tetrahydroaminoacridine/pilocarpine treatment suppresses high voltage spindle activity in aged rats

Brain Res Bull. 1991 Aug;27(2):237-9. doi: 10.1016/0361-9230(91)90074-t.

Abstract

The present study evaluated the effects of combined alpha2-antagonist (atipamezole) and anticholinesterase (tetrahydroaminoacridine, THA) or muscarinic agonist (pilocarpine) treatments on the high voltage spindle (HVS) activity in aged rats. On their own, high doses of THA (3 mg/kg), pilocarpine (3 mg/kg) and atipamezole (3 mg/kg) suppressed HVS activity. Low doses of THA (1 mg/kg), pilocarpine (1 mg/kg) and atipamezole (1 mg/kg) did not suppress HVS activity. Combinations of low doses of atipamezole and THA or pilocarpine suppressed HVS activity. Our results suggest that 1) the administration of alpha2-antagonist blocked the age-related deficit of thalamocortical activation, 2) a combination of alpha2-antagonist and a cholinergic drug may more effectively stabilize age-related HVS activity than either of the treatments alone.

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Aging / physiology*
  • Animals
  • Drug Combinations
  • Electrophysiology
  • Imidazoles / pharmacology*
  • Male
  • Muscle Spindles / drug effects*
  • Muscle Spindles / physiology
  • Pilocarpine / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Reaction Time
  • Tacrine / pharmacology*

Substances

  • Adrenergic alpha-Antagonists
  • Drug Combinations
  • Imidazoles
  • Pilocarpine
  • atipamezole
  • Tacrine